An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir

@inproceedings{Soliman2018AnUF,
  title={An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir},
  author={Megan Sue Soliman and Youssef Soliman and Qamar Ashfaq Ahmad and Roopa Yarlagadda},
  booktitle={Journal of community hospital internal medicine perspectives},
  year={2018}
}
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the third highest cause of cancer mortality worldwide. Risk factors include chronic liver disease and cirrhosis of various causes including chronic hepatitis B and C. In cases of chronic hepatitis C virus (HCV), HCC usually does not manifest unless the liver has become cirrhotic. Fortunately, novel treatments for hepatitis C including ledipasvir/sofosbuvir can cure patients from their disease and as a result, may… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-3 OF 3 REFERENCES

Hepatocellular carcinoma in the noncirrhotic liver.

  • AJR. American journal of roentgenology
  • 2014
VIEW 1 EXCERPT

Hepatocellular carcinoma.

  • The New England journal of medicine
  • 2011
VIEW 1 EXCERPT

The etiology of hepatocellular carcinoma and consequences for treatment

AJ Sanyala, SK Yoonb, R. Lencionic
  • Oncologist
  • 2010
VIEW 1 EXCERPT